|Home||» Products||» Gastrointestinal Drugs||» Granisetron hydrochloride|
- Minimum Order Quantity
GRANICIP Injection is a serotonin-3 (5-HT3)-receptor antagonist indicated for the prevention of nausea and/or vomiting associated with initial and repeat courses of emetogenic cancer therapy (chemotherapy or radiotherapy), including high-dose cisplatin.
- Main Export Market(s)
- Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia